Wave Life Sciences Ltd. - Ordinary Shares (WVE): Price and Financial Metrics

Wave Life Sciences Ltd. - Ordinary Shares (WVE)

Today's Latest Price: $7.07 USD

0.23 (-3.15%)

Updated Oct 30 4:00pm

Add WVE to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 240 in Medical - Pharmaceuticals

See all "A" rated Strong Buy stocks

WVE Stock Summary

  • Wave Life Sciences Ltd's capital turnover -- a measure of revenue relative to shareholder's equity -- is better than just 3.52% of US listed stocks.
  • WVE's price/sales ratio is 20.59; that's higher than the P/S ratio of 92.72% of US stocks.
  • As for revenue growth, note that WVE's revenue has grown -33.3% over the past 12 months; that beats the revenue growth of just 7.78% of US companies in our set.
  • Stocks with similar financial metrics, market capitalization, and price volatility to Wave Life Sciences Ltd are VBLT, SYBX, KALV, NTLA, and FIXX.
  • Visit WVE's SEC page to see the company's official filings. To visit the company's web site, go to www.wavelifesciences.com.

WVE Stock Price Chart Interactive Chart >

Price chart for WVE

WVE Price/Volume Stats

Current price $7.07 52-week high $39.98
Prev. close $7.30 52-week low $6.61
Day low $6.76 Volume 1,074,900
Day high $7.44 Avg. volume 769,855
50-day MA $10.81 Dividend yield N/A
200-day MA $9.58 Market Cap 257.73M

Wave Life Sciences Ltd. - Ordinary Shares (WVE) Company Bio

WAVE Life Sciences Pte. Ltd., a preclinical biopharmaceutical company, designs, develops, and commercializes nucleic acid therapeutic candidates. The company was founded in 2012 and is based in Simgapore.

WVE Latest News Stream

Event/Time News Detail
Loading, please wait...

WVE Latest Social Stream

Loading social stream, please wait...

View Full WVE Social Stream

Latest WVE News From Around the Web

Below are the latest news stories about Wave Life Sciences Ltd that investors may wish to consider to help them evaluate WVE as an investment opportunity.

Wave Life Sciences (WVE) Presents at H.C. Wainwright Annual Global Investment Conference - Slideshow

The following slide deck was published by Wave Life Sciences Ltd. in conjunction with this event....

SA Transcripts on Seeking Alpha | September 18, 2020

WAVE Life Sciences: Q2 Earnings Insights

Shares of WAVE Life Sciences (NASDAQ:WVE) moved higher by 1% in pre-market trading after the company reported Q2 results. Quarterly Results Earnings per …

Benzinga | August 10, 2020

Wave Life Sciences to Webcast Conference Call of Second Quarter 2020 Financial Results on August 10, 2020

CAMBRIDGE, Mass., July 27, 2020 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage genetic medicines company committed to…

GlobeNewswire | July 27, 2020

Will Wave Life Sciences (WVE) Report Negative Q2 Earnings? What You Should Know

Wave Life Sciences (WVE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Yahoo | July 27, 2020

Are Options Traders Betting on a Big Move in Wave Life Sciences (WVE) Stock?

Investors need to pay close attention to Wave Life Sciences (WVE) stock based on the movements in the options market lately.

Yahoo | June 24, 2020

Read More 'WVE' Stories Here

WVE Price Returns

1-mo -13.57%
3-mo -19.48%
6-mo -17.16%
1-year -73.20%
3-year -69.26%
5-year N/A
YTD -11.79%
2019 -80.93%
2018 19.77%
2017 34.23%
2016 63.95%
2015 N/A

Continue Researching WVE

Want to see what other sources are saying about Wave Life Sciences Ltd's financials and stock price? Try the links below:

Wave Life Sciences Ltd (WVE) Stock Price | Nasdaq
Wave Life Sciences Ltd (WVE) Stock Quote, History and News - Yahoo Finance
Wave Life Sciences Ltd (WVE) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!

Page generated in 1.3035 seconds.